Background Background The Outcomes of
The Outcomes of Depression International Network Depression International Network (ODIN) trial evaluated the effect of two (ODIN) trial evaluated the effect of two psychological interventions for the psychological interventions for the treatment of depression in primary care. treatment of depression in primary care. Only about half of the patients in the Only about half of the patients in the treatment arm complied with the offer of treatment arm complied with the offer of treatment, prompting the question:'what treatment, prompting the question:'what was the effect of treatment in those was the effect of treatment in those patients who actually received it?' patients who actually received it?' Aims Aims To illustrate the estimation of the To illustrate the estimation of the effect of receipt of treatment in a effect of receipt of treatment in a randomised controlled trial subjectto randomised controlled trial subjectto non-compliance and loss to follow-up. non-compliance and loss to follow-up.
Method Method We estimated the complier
We estimated the complier average causal effect (CACE) of average causal effect (CACE) of treatment. treatment.
Results

Results In the ODIN trial the effect of
In the ODIN trial the effect of receipt of psychological intervention (an receipt of psychological intervention (an average of about 4 points on the Beck average of about 4 points on the Beck Depression Inventory) is abouttwice that Depression Inventory) is abouttwice that of offering it. of offering it.
Conclusions Conclusions The statistical analysis of
The statistical analysis of the results of a clinical trial subjectto nonthe results of a clinical trial subjectto noncompliance to allocated treatment is now compliance to allocated treatment is now reasonably straightforward through reasonably straightforward through estimation of a CACE and investigators estimation of a CACE and investigators should be encouraged to presentthe should be encouraged to presentthe results of analyses of this type as a routine results of analyses of this type as a routine component of a trial report. component of a trial report.
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Mr Jones has come to the general practiMr Jones has come to the general practitioner's clinic complaining of symptoms of tioner's clinic complaining of symptoms of depression. An obvious question for the depression. An obvious question for the general practitioner to ask herself is: 'If I general practitioner to ask herself is: 'If I were to offer psychological treatment to were to offer psychological treatment to Mr Jones, would he benefit from the receipt Mr Jones, would he benefit from the receipt of this treatment?' What can the results of a of this treatment?' What can the results of a randomised controlled trial, particularly randomised controlled trial, particularly intention-to-treat (ITT) estimates of treatintention-to-treat (ITT) estimates of treatment effects, tell the general practitioner ment effects, tell the general practitioner about the answer to this question? A conabout the answer to this question? A conventional ITT effect estimate, at best, might ventional ITT effect estimate, at best, might provide a good answer to a question of the provide a good answer to a question of the form 'If I were to offer psychological treatform 'If I were to offer psychological treatment to Mr Jones, by how much would he ment to Mr Jones, by how much would he benefit from the offer?' Even if there are benefit from the offer?' Even if there are no problems in generalising from the results no problems in generalising from the results of a randomised controlled trial, the answer of a randomised controlled trial, the answer to this question is only the same as that to to this question is only the same as that to the former question if there is complete the former question if there is complete take-up of the offer of treatment. That is, take-up of the offer of treatment. That is, the ITT estimate of a treatment effect is a the ITT estimate of a treatment effect is a valid estimate of the receipt of treatment valid estimate of the receipt of treatment only if there is 100% acceptance of the only if there is 100% acceptance of the treatment in the randomly selected group treatment in the randomly selected group offered it and if none of those who are ranoffered it and if none of those who are randomly allocated to be the controls get access domly allocated to be the controls get access to the treatment. But most real trials in this to the treatment. But most real trials in this field are not like that. If we are really interfield are not like that. If we are really interested in assessing the size of the benefit of ested in assessing the size of the benefit of receipt of treatment, as opposed to merely receipt of treatment, as opposed to merely the offer of it, then our statistical analysis the offer of it, then our statistical analysis needs to proceed beyond ITT. Using the needs to proceed beyond ITT. Using the phrase of Heckman phrase of Heckman et al et al (1998) , we need (1998), we need to estimate 'the effect of treatment on the to estimate 'the effect of treatment on the treated'. Newcombe (1988) refers to an 'extreated '. Newcombe (1988) refers to an 'explanatory' estimate of a treatment effect as planatory' estimate of a treatment effect as opposed to the more familiar 'pragmatic' opposed to the more familiar 'pragmatic' (or ITT) estimate. The purpose of the (or ITT) estimate. The purpose of the present paper is to use the results of the present paper is to use the results of the Outcomes of Depression International NetOutcomes of Depression International Network (ODIN) trial (Dowrick work (ODIN) trial (Dowrick et al et al, 2000) to , 2000) to illustrate how this might be done. illustrate how this might be done.
METHOD METHOD
The ODIN trial is a European project The ODIN trial is a European project studying the prevalence and outcomes of studying the prevalence and outcomes of depression in urban and rural communities depression in urban and rural communities (Dowrick (Dowrick et al et al, 2000; Ajuso-Mateos , 2000; Ajuso-Mateos et al et al 2001) . One objective of the ODIN trial 2001). One objective of the ODIN trial was to assess the efficacy of psychological was to assess the efficacy of psychological interventions. We identified two simple, interventions. We identified two simple, reproducible interventions that could be dereproducible interventions that could be delivered in the community: problem-solving livered in the community: problem-solving and group sessions of a course on the preand group sessions of a course on the prevention of depression (psychoeducation). vention of depression (psychoeducation). The outcomes following either of these The outcomes following either of these two treatments or a treatment-as-usual two treatments or a treatment-as-usual control were compared in a multi-centre control were compared in a multi-centre randomised controlled trial. The main randomised controlled trial. The main results from this trial have been described results from this trial have been described previously (Dowrick previously (Dowrick et al et al, 2000) . , 2000). Problem-solving appeared to be more Problem-solving appeared to be more acceptable than a course of psychoacceptable than a course of psychoeducation (as measured by compliance education (as measured by compliance patterns in the two treatment groups) but patterns in the two treatment groups) but both led to improved outcomes (in comparboth led to improved outcomes (in comparison with the controls) when measured 6 ison with the controls) when measured 6 months after randomisation. At 12 months, months after randomisation. At 12 months, however, the outcomes in all three groups however, the outcomes in all three groups were very similar. were very similar.
The detailed aims of the present paper The detailed aims of the present paper are to study in further depth the estimation are to study in further depth the estimation of selected measures of efficacy of these of selected measures of efficacy of these psychological treatments. These efficacy psychological treatments. These efficacy measures are formally defined in terms of measures are formally defined in terms of two types of average treatment effect using two types of average treatment effect using recently developed theories of causal inferrecently developed theories of causal inference as applied to randomised controlled ence as applied to randomised controlled trials in which there is the possibility of trials in which there is the possibility of both non-compliance to allocated treatboth non-compliance to allocated treatment and subsequent drop-out (i.e. missing ment and subsequent drop-out (i.e. missing outcome data). Our aim is to provide an outcome data). Our aim is to provide an illustration of an analysis strategy that illustration of an analysis strategy that might be used as an informal model to be might be used as an informal model to be applied to the analysis of a wide variety of applied to the analysis of a wide variety of trials of complex interventions in psytrials of complex interventions in psychiatry. A further aim of this paper is to chiatry. A further aim of this paper is to illustrate approaches to the assessment of illustrate approaches to the assessment of the sensitivity of the estimates of treatment the sensitivity of the estimates of treatment effects to various assumptions concerning effects to various assumptions concerning the impact of merely offering treatmentthe impact of merely offering treatmentthe definition of receipt of treatment the definition of receipt of treatment (compliance) -after adjusting for the (compliance) -after adjusting for the influence of non-compliance on loss to influence of non-compliance on loss to follow-up. follow-up.
The present report, unlike many The present report, unlike many descriptions of the results of randomised descriptions of the results of randomised controlled trials, actually emphasises the controlled trials, actually emphasises the problems arising from non-compliance problems arising from non-compliance and subsequent loss to follow-up. This and subsequent loss to follow-up. This approach is chosen for two reasons: to approach is chosen for two reasons: to obtain valid estimates of average treatment obtain valid estimates of average treatment effects of interest and to challenge our effects of interest and to challenge our assumptions concerning the influence of assumptions concerning the influence of patient preferences on the outcome of being patient preferences on the outcome of being offered and/or receiving treatment. Both offered and/or receiving treatment. Both should lead to the possibility of more inforshould lead to the possibility of more informative designs for complex intervention mative designs for complex intervention studies. We hope that we might be able to studies. We hope that we might be able to stimulate other investigators to explore stimulate other investigators to explore the data from their own trials more the data from their own trials more thoroughly and not simply sweep the thoroughly and not simply sweep the problems 'under the carpet'. problems 'under the carpet'.
Study design Study design
The ODIN trial involved nine study centres The ODIN trial involved nine study centres in Finland (2), the Republic of Ireland (2), in Finland (2), the Republic of Ireland (2), Norway (2), Spain (1) and the UK (2). Norway (2), Spain (1) and the UK (2). The trial was designed to compare the outThe trial was designed to compare the outcomes of problem-solving treatment or a comes of problem-solving treatment or a depression prevention course (psychodepression prevention course (psychoeducation) with outcome in a control group education) with outcome in a control group receiving no intervention. Within each receiving no intervention. Within each centre patients were allocated randomly centre patients were allocated randomly to receive either one of the two types of to receive either one of the two types of treatment (the treatment group) or no intertreatment (the treatment group) or no intervention (the control group). Problemvention (the control group). Problemsolving (but not psychoeducation) was solving (but not psychoeducation) was available in Spain, Finland (both centres) available in Spain, Finland (both centres) and the UK (one centre). Psychoeducation and the UK (one centre). Psychoeducation (but not problem-solving) was available in (but not problem-solving) was available in Ireland (both centres) and Norway (both Ireland (both centres) and Norway (both centres). The second UK centre was the centres). The second UK centre was the only one in the trial in which patients could only one in the trial in which patients could be allocated randomly to any of the three be allocated randomly to any of the three treatment arms. The main implication of treatment arms. The main implication of this complex design is that the formal this complex design is that the formal analysis should involve stratification by analysis should involve stratification by centre (to ensure that the treatment groups centre (to ensure that the treatment groups are being compared with the appropriate are being compared with the appropriate controls). Further details of the design, controls). Further details of the design, including detailed descriptions of the including detailed descriptions of the interventions offered, are provided in interventions offered, are provided in Dowrick Dowrick et al et al (2000) . Note that the results (2000) . Note that the results from 427 randomised patients are analysed from 427 randomised patients are analysed in the present report; Dowrick in the present report; Dowrick et al et al (2000) (2000) used 426, as one patient had been inused 426, as one patient had been inadvertently missed from the previous advertently missed from the previous analysis owing to clerical error. Because analysis owing to clerical error. Because of the small number of patients in the two of the small number of patients in the two centres from Ireland, in the present centres from Ireland, in the present analysis the two Irish centres are treated analysis the two Irish centres are treated as one. as one.
For the purpose of the present paper For the purpose of the present paper there were three measured outcomes of there were three measured outcomes of treatment allocation (randomisation): how treatment allocation (randomisation): how well the patient adhered to (complied with) well the patient adhered to (complied with) the allocation treatment; whether or not the the allocation treatment; whether or not the patient was lost to follow-up (six months patient was lost to follow-up (six months after randomisation); and, if available, a after randomisation); and, if available, a measure of the severity of depression at measure of the severity of depression at follow-up. The latter was assessed using follow-up. The latter was assessed using the total score of the Beck Depression the total score of the Beck Depression Inventory (BDI; Beck Inventory (BDI; Beck et al et al, 1961) . Adher-, 1961) . Adherence to the allocated treatment was ence to the allocated treatment was measured on a four-point nominal scale: measured on a four-point nominal scale: 'Attended', 'Refused', 'Discontinued' and 'Attended', 'Refused', 'Discontinued' and 'Did not attend'. In order to proceed with 'Did not attend'. In order to proceed with further analyses, this scale was dichotofurther analyses, this scale was dichotomised in one of two ways: for compliance mised in one of two ways: for compliance A, 'Attended' was coded 1 and the rest 0; A, 'Attended' was coded 1 and the rest 0; for compliance B, 'Attended' and 'Disfor compliance B, 'Attended' and 'Discontinued' were both coded 1 and the rest continued' were both coded 1 and the rest 0. A patient was deemed to have received 0. A patient was deemed to have received treatment if he or she was in the allocated treatment if he or she was in the allocated treatment group and the relevant comtreatment group and the relevant compliance code was 1 (patients did not have pliance code was 1 (patients did not have access to treatment if they had been access to treatment if they had been allocated to the control group). allocated to the control group).
Analysis strategy Analysis strategy
Initial description of the data Initial description of the data First, the frequencies for each of the First, the frequencies for each of the patterns of adherence to allocated treatment patterns of adherence to allocated treatment are examined for each treatment centre are examined for each treatment centre (separately for each treatment type for the (separately for each treatment type for the UK centre offering both treatments). Then UK centre offering both treatments). Then the patients who were allocated to the the patients who were allocated to the treatment group are classified as compliers treatment group are classified as compliers or non-compliers, according to compliance or non-compliers, according to compliance A or B. Observed compliance status has A or B. Observed compliance status has three levels: 'Control', 'Yes' or 'No'. three levels: 'Control', 'Yes' or 'No'. Patterns of observed compliance status are Patterns of observed compliance status are examined for each treatment centre, examined for each treatment centre, together with the numbers of patients in together with the numbers of patients in each category providing depression severity each category providing depression severity ratings. Finally, means for the depression ratings. Finally, means for the depression severity ratings are calculated for each of severity ratings are calculated for each of the compliance categories within each of the compliance categories within each of the treatment centres. These preliminary the treatment centres. These preliminary data descriptions enable us to evaluate the data descriptions enable us to evaluate the level of adherence to allocated treatment, level of adherence to allocated treatment, whether the levels of adherence depend on whether the levels of adherence depend on the nature of the treatment on offer and the nature of the treatment on offer and the amount of variability in adherence from the amount of variability in adherence from one treatment centre to another. They also one treatment centre to another. They also enable us to see whether the rate of loss enable us to see whether the rate of loss to follow-up is dependent on compliance to follow-up is dependent on compliance status and how this varies from one centre status and how this varies from one centre to another. Finally, we see how severity of to another. Finally, we see how severity of depression varies with compliance status depression varies with compliance status within and across treatment centres. These within and across treatment centres. These data then provide the material for the more data then provide the material for the more detailed analyses described below. detailed analyses described below.
In-depth analysis In-depth analysis Assumptions concerning non-compliance Assumptions concerning non-compliance. We . We start by assuming that the patients taking start by assuming that the patients taking part in the trial belong to one of two part in the trial belong to one of two potentially latent classes: compliers and potentially latent classes: compliers and non-compliers. In the treatment group the non-compliers. In the treatment group the non-compliers are those who fail to non-compliers are those who fail to receive treatment when they are offered it. receive treatment when they are offered it.
In the control group they are those patients In the control group they are those patients who would have failed to receive treatment who would have failed to receive treatment had they been offered it. Compliers are had they been offered it. Compliers are those who received treatment in the treatthose who received treatment in the treatment group and those in the control group ment group and those in the control group who would have received treatment had who would have received treatment had they been offered it. We can observe comthey been offered it. We can observe compliance status in the treatment group but pliance status in the treatment group but it is latent or unobservable in the control it is latent or unobservable in the control group. group.
Randomisation ensures that, on average, Randomisation ensures that, on average, the proportion of compliers in the control the proportion of compliers in the control group is the same as that in the treatment group is the same as that in the treatment group (Bloom, 1984; Sommer & Zeger, group (Bloom, 1984; Sommer & Zeger, 1991) . This means that we can estimate 1991). This means that we can estimate the proportion of unobserved compliers in the proportion of unobserved compliers in the control group (or, equivalently, the prothe control group (or, equivalently, the proportion of compliers in the trial as a whole, portion of compliers in the trial as a whole, p p c c ) from the proportion observed in the ) from the proportion observed in the treatment group ( treatment group (P P c c ).
).
Definitions of treatment effects
Definitions of treatment effects. We define . We define the average causal effect (ACE) of treatthe average causal effect (ACE) of treatment as the difference between the 6-month ment as the difference between the 6-month average BDI score for the treatment group average BDI score for the treatment group and that for the control group (regardless and that for the control group (regardless of compliance status or whether the outof compliance status or whether the outcome is actually observed). An alternative come is actually observed). An alternative term is the 'average treatment effect' term is the 'average treatment effect' (Angrist (Angrist et al et al, 1996) . This is the treatment , 1996). This is the treatment effect that we are trying to estimate in a effect that we are trying to estimate in a so-called ITT analysis. It is the difference so-called ITT analysis. It is the difference in outcomes between the two treatment in outcomes between the two treatment groups as randomised, as opposed to groups as randomised, as opposed to treatment actually received. treatment actually received.
We define the complier average causal We define the complier average causal effect (CACE) as the difference between effect (CACE) as the difference between the 6-month average BDI score for the comthe 6-month average BDI score for the compliers in the treatment group and that for pliers in the treatment group and that for the compliers in the control group the compliers in the control group (regardless of whether the outcome is (regardless of whether the outcome is actually observed). An alternative term is actually observed). An alternative term is the 'local average treatment effect' (Angrist the 'local average treatment effect' (Angrist et al et al, 1996) . For reasons clearly explained , 1996). For reasons clearly explained by Sheiner & Rubin (1995) and by by Sheiner & Rubin (1995) and by Frangakis & Rubin (1999), we do not Frangakis & Rubin (1999), we do not consider effects estimated by methods consider effects estimated by methods involving analysis 'per protocol' or 'as involving analysis 'per protocol' or 'as treated' (the former compares the compliers treated' (the former compares the compliers in the treatment group with all of the in the treatment group with all of the controls, and the latter compares those controls, and the latter compares those who receive treatment with those who do who receive treatment with those who do not, regardless of random allocation) -not, regardless of random allocation) -neither being estimates of valid treatment neither being estimates of valid treatment effects described in this paper. effects described in this paper.
Exclusion restriction Exclusion restriction. Given the treatment . Given the treatment received, we assume that outcome is indereceived, we assume that outcome is independent of random allocation. That is, the pendent of random allocation. That is, the offer of treatment, in itself, does not offer of treatment, in itself, does not influence outcome (Bloom, 1984 ; Sommer influence outcome (Bloom, 1984; Sommer & Zeger, 1991) . This assumption is often & Zeger, 1991). This assumption is often referred to as an 'exclusion restriction' referred to as an 'exclusion restriction' (Angrist (Angrist et al et al, 1996) . From this assumption , 1996) . From this assumption we can assume that the mean BDI score for we can assume that the mean BDI score for the non-compliers in the control group is, the non-compliers in the control group is, on average, the same as that for the nonon average, the same as that for the noncompliers in the treatment group. This compliers in the treatment group. This enables us to estimate the unobserved mean enables us to estimate the unobserved mean for non-compliers in the control group by for non-compliers in the control group by the observed average for the non-compliers the observed average for the non-compliers in the treatment group. in the treatment group.
It is straightforward to show from the It is straightforward to show from the exclusion restriction assumption that exclusion restriction assumption that
where where p p c c is the proportion of compliers in is the proportion of compliers in the trial (Angrist the trial (Angrist et al et al, 1996) . Typically, , 1996) . Typically, we proceed by first estimating the CACE we proceed by first estimating the CACE and then, if we require an estimate of the and then, if we require an estimate of the ACE, using this to get an estimate of the ACE, using this to get an estimate of the ACE from equation (1) together with our ACE from equation (1) (i.e. P P c c ). In the simple situa-). In the simple situation where outcome measures are available tion where outcome measures are available for all trial participants (i.e. there is no loss for all trial participants (i.e. there is no loss to follow-up), then the required estimate to follow-up), then the required estimate for the ACE is the familiar ITT estimate. for the ACE is the familiar ITT estimate. In this circumstance we can then simply In this circumstance we can then simply estimate the effect of receiving treatment estimate the effect of receiving treatment (equivalent to the CACE) from (equivalent to the CACE) from
Details can be found in Angrist Details can be found in Angrist et al et al (1996) . (1996). When we have both non-compliance and When we have both non-compliance and non-ignorable missing follow-up data (see non-ignorable missing follow-up data (see below), however, the naıve but frequently below), however, the naïve but frequently used ITT estimates are likely to be biased used ITT estimates are likely to be biased and we have to approach the analysis via and we have to approach the analysis via CACE estimation by taking into account CACE estimation by taking into account the missing data mechanism (Frangakis & the missing data mechanism (Frangakis & Rubin, 1999) . Rubin, 1999) .
Missing data mechanisms and simple methods Missing data mechanisms and simple methods of CACE estimation of CACE estimation. If, in addition to . If, in addition to non-compliance, we also have missing non-compliance, we also have missing outcome data then we have to make outcome data then we have to make further assumptions concerning the missfurther assumptions concerning the missing data mechanism. The first option is ing data mechanism. The first option is to assume that the missing data mechanto assume that the missing data mechanism is ignorable. Here the data are either ism is ignorable. Here the data are either missing completely at random or missing missing completely at random or missing at random, in the sense defined by Little at random, in the sense defined by Little & Rubin (2002) . Looking ahead, it is clear & Rubin (2002) . Looking ahead, it is clear from a glance at Table 2 that the outcome from a glance at Table 2 that the outcome data are not missing completely at random data are not missing completely at random (loss to follow-up is clearly related to (loss to follow-up is clearly related to compliance status). But suppose, for examcompliance status). But suppose, for example, in the simple situation where there are ple, in the simple situation where there are no measured covariates, that the probno measured covariates, that the probability of being missing is determined by ability of being missing is determined by observed compliance status (complier, observed compliance status (complier, non-complier or a member of the control non-complier or a member of the control group) and that, conditional on observed group) and that, conditional on observed compliance status, outcome is statistically compliance status, outcome is statistically independent of whether outcome is actuindependent of whether outcome is actually observed. Here, the outcome data ally observed. Here, the outcome data are missing at random (MAR). Under are missing at random (MAR). Under these assumptions it is straightforward to these assumptions it is straightforward to show that show that (3) simplifies to the come data, equation (3) simplifies to the estimator first described by Bloom (1984) . estimator first described by Bloom (1984) . The standard error of this so-called The standard error of this so-called moments estimate can be obtained using moments estimate can be obtained using the delta technique or a simple bootstrap the delta technique or a simple bootstrap (Efron & Tibshirani, 1993) . (Efron & Tibshirani, 1993) .
The alternative missing data option is The alternative missing data option is that they are non-ignorable (Little & that they are non-ignorable (Little & Rubin, 2002) . That is, whether a patient Rubin, 2002) . That is, whether a patient has a missing outcome is dependent on has a missing outcome is dependent on the value of that outcome, even after conthe value of that outcome, even after conditioning on observed variables such as ditioning on observed variables such as compliance status and baseline covariates. compliance status and baseline covariates. This is a much more difficult problem to This is a much more difficult problem to deal with and we refer the interested reader deal with and we refer the interested reader to a recent paper on this topic by Frangakis to a recent paper on this topic by Frangakis & Rubin (1999 Dunn (2002b b) . In order to ). In order to keep the technical details to a minimum, keep the technical details to a minimum, we do not pursue this option in any detail we do not pursue this option in any detail in the present paper. in the present paper.
Refinement of CACE estimation: incorporating Refinement of CACE estimation: incorporating baseline covariates baseline covariates. Although technically . Although technically more difficult, if we have access to baseline more difficult, if we have access to baseline covariates (including treatment centre) we covariates (including treatment centre) we can develop more efficient (i.e. precise) can develop more efficient (i.e. precise) CACE estimation methods. We can also CACE estimation methods. We can also get more stable estimates of the average get more stable estimates of the average treatment effects within each of the centres. treatment effects within each of the centres. Maximum likelihood methods, based on Maximum likelihood methods, based on the joint distribution of the binary complithe joint distribution of the binary compliance status and a normally distributed outance status and a normally distributed outcome measure, have been developed by come measure, have been developed by Angrist Angrist et al et al (1996) , Little & Yau (1998 ) (1996 , Little & Yau (1998) In the present study, CACE models In the present study, CACE models incorporating the potential use of baseline incorporating the potential use of baseline covariates (initial BDI score and centre covariates (initial BDI score and centre membership) to predict both compliance membership) to predict both compliance status and outcome were fitted via maxistatus and outcome were fitted via maximum likelihood estimation using the expecmum likelihood estimation using the expectation maximisation algorithm ( tation maximisation algorithm (Mplus Mplus Version 2.12; Muthen & Muthen, 1998-Version 2.12; Muthén & Muthén, 1998 -2002 . The use of the latter software pack-2002). The use of the latter software package in the application of this methodology age in the application of this methodology on randomised controlled trial data with on randomised controlled trial data with non-compliance is illustrated in detail by non-compliance is illustrated in detail by Jo & Muthen (2001) , although they do Jo & Muthén (2001), although they do not consider problems arising from missing not consider problems arising from missing outcome data. outcome data.
Sensitivity analysis Sensitivity analysis. Rather precise assump-. Rather precise assumptions (e.g. concerning the definition of comtions (e.g. concerning the definition of compliance, the missing data mechanism and pliance, the missing data mechanism and exclusion restriction) are vital components exclusion restriction) are vital components of the analytical approaches described of the analytical approaches described above for the estimation of average treatabove for the estimation of average treatment effects. Having to make these assumpment effects. Having to make these assumptions is both a strength and a weakness of tions is both a strength and a weakness of these approaches. If we get the assumptions these approaches. If we get the assumptions wrong we risk invalid inferences, but a wrong we risk invalid inferences, but a thorough examination of the implications thorough examination of the implications of the assumptions helps to understand of the assumptions helps to understand what might be going on in a psychological what might be going on in a psychological treatment trial. They force us to think more treatment trial. They force us to think more about the trial process and to clarify what about the trial process and to clarify what we are really interested in estimating. we are really interested in estimating. Another vital component of the analytical Another vital component of the analytical approach therefore is to attempt to evaluate approach therefore is to attempt to evaluate the sensitivity of our treatment effect the sensitivity of our treatment effect estimates to changes in these assumptions. estimates to changes in these assumptions.
All preliminary analyses and checks of All preliminary analyses and checks of the sensitivity of the treatment effects to the sensitivity of the treatment effects to assumptions concerning the definition of assumptions concerning the definition of compliance were carried out using Stata compliance were carried out using Stata Version 7.0 (StataCorp, 2001 ). An exploraVersion 7.0 (StataCorp, 2001 ). An exploration of the sensitivity of the CACE estition of the sensitivity of the CACE estimates to the validity of the main exclusion mates to the validity of the main exclusion restriction assumption (treatment allorestriction assumption (treatment allocation does not influence outcome except cation does not influence outcome except through its effect on treatment received), through its effect on treatment received), using either of the two definitions of comusing either of the two definitions of compliance, was carried out as described by Jo pliance, was carried out as described by Jo ( 2002  (2002a a, ,b b) . Readers are also referred to ). Readers are also referred to Heckman Heckman et al et al (1998) and Hirano (1998) and Hirano et al et al (2000) . (2000).
RESULTS RESULTS
Preliminary examination of the Preliminary examination of the data data Table 1 shows the patterns of adherence to Table 1 shows the patterns of adherence to the offered treatment (i.e. excluding conthe offered treatment (i.e. excluding controls) in each of the nine centres (separately trols) in each of the nine centres (separately for the two types of treatment offered by for the two types of treatment offered by centre 7). To illustrate the variation in the centre 7). To illustrate the variation in the patterns of adherence in more detail, we patterns of adherence in more detail, we look at patterns of compliance using comlook at patterns of compliance using compliance A (Table 2 ). Compliance rates vary pliance A (Table 2) . Compliance rates vary greatly from one centre to another (ranging greatly from one centre to another (ranging from 40% in centre 1 to 74% in centre 3). from 40% in centre 1 to 74% in centre 3). Some of the variation may be explained by Some of the variation may be explained by the type of treatment being offered, but we the type of treatment being offered, but we do not stress this aspect of the results do not stress this aspect of the results because the design of the trial leads to this because the design of the trial leads to this source of variation being almost completely source of variation being almost completely confounded with the centre effects. These confounded with the centre effects. These compliance rates may appear to be rather compliance rates may appear to be rather low, but the reader must bear in mind that low, but the reader must bear in mind that the participants in the ODIN trial were the participants in the ODIN trial were recruited through a case-finding exercise. recruited through a case-finding exercise. They were not patients who had actively They were not patients who had actively sought help. sought help.
Loss to follow-up (i.e. missing outcome Loss to follow-up (i.e. missing outcome data) varies from one centre to another but data) varies from one centre to another but is also markedly dependent on compliance is also markedly dependent on compliance status. Loss to follow-up in the compliers status. Loss to follow-up in the compliers in the treatment group is very infrequent. in the treatment group is very infrequent. In four of the nine centres the compliers In four of the nine centres the compliers provide 100% of the required outcome provide 100% of the required outcome data, with follow-up of those in the other data, with follow-up of those in the other five centres ranging from 79% (centre 7) five centres ranging from 79% (centre 7) to 91% (centre 5). However, loss to to 91% (centre 5). However, loss to follow-up is both more variable and more follow-up is both more variable and more common in the non-compliers of the treatcommon in the non-compliers of the treatment group; here, follow-up rates range ment group; here, follow-up rates range from 22% (centre 1) to 75% (centre 4). In from 22% (centre 1) to 75% (centre 4). In no case is the within-centre follow-up rate no case is the within-centre follow-up rate for the non-compliers as high as that for for the non-compliers as high as that for the corresponding compliers. As might be the corresponding compliers. As might be expected, the follow-up rates for the conexpected, the follow-up rates for the controls lies somewhere between those for the trols lies somewhere between those for the compliers and non-compliers in the treatcompliers and non-compliers in the treatment group. ment group.
Moving on to consider the severity of Moving on to consider the severity of depression at outcome (the mean BDI score depression at outcome (the mean BDI score at 6 months) we see that, on average, at 6 months) we see that, on average, patients offered treatment do better than patients offered treatment do better than the controls (bottom three rows of Table  the controls (bottom three rows of Table  3 ). However, this difference is not always 3). However, this difference is not always apparent within each of the centres. On apparent within each of the centres. On average, the compliers in the treatment average, the compliers in the treatment group have very similar outcomes to those group have very similar outcomes to those who do not comply with the offered treatwho do not comply with the offered treatment (last two rows of Table 3 ) but again ment (last two rows of Table 3 ) but again there is a considerable amount of varithere is a considerable amount of variability in this difference from one centre ability in this difference from one centre 3 2 6 3 2 6 3. The two treatment centres from Ireland were combined for the purposes of analyses in the present paper. 3. The two treatment centres from Ireland were combined for the purposes of analyses in the present paper.
to another. In centres 2-5 the compliers to another. In centres 2-5 the compliers appear to fare better than the non-compliers. appear to fare better than the non-compliers. In centres 1, 6, 7 and 8, however, the nonIn centres 1, 6, 7 and 8, however, the noncompliers fare better. Again, we do not compliers fare better. Again, we do not concentrate on the differences in effects concentrate on the differences in effects for the two types of psychological interfor the two types of psychological intervention because these differences are vention because these differences are confounded by differences between centres. confounded by differences between centres. Returning to the data for the whole trial Returning to the data for the whole trial (bottom three rows of Table 3 ), the equality (bottom three rows of Table 3 ), the equality of the mean of the BDI scores for the of the mean of the BDI scores for the compliers and non-compliers in the treatcompliers and non-compliers in the treatment group, together with the exclusion ment group, together with the exclusion restriction (the assumption that the mean restriction (the assumption that the mean BDI score for the non-compliers in the BDI score for the non-compliers in the control group is the same as that for control group is the same as that for those in the treatment group), implies that those in the treatment group), implies that the compliers in the control group have a the compliers in the control group have a worse outcome than the corresponding worse outcome than the corresponding non-compliers. Attempts to understand non-compliers. Attempts to understand why this might be so are detailed in the why this might be so are detailed in the Discussion. Discussion.
The CACE estimation The CACE estimation
We now look at simple CACE estimates We now look at simple CACE estimates (i.e. moment estimates based on Equation (i.e. moment estimates based on Equation (3)), ignoring centre membership. These (3)), ignoring centre membership. These estimates are derived using either of the estimates are derived using either of the two definitions of compliance. 71.88). None of 1.88). None of these differences appears, at this stage, to be these differences appears, at this stage, to be statistically significant (the ratio of the statistically significant (the ratio of the estimate to its standard error is estimate to its standard error is 5 52). 2). We now present the result of a more We now present the result of a more formal series of analyses (Table 4) . We use formal series of analyses (Table 4) . We use maximum likelihood estimation (assuming maximum likelihood estimation (assuming normality of the outcome BDI scores) and normality of the outcome BDI scores) and allow for the baseline BDI score as a covariallow for the baseline BDI score as a covariate. All 427 subjects are included in the ate. All 427 subjects are included in the analysis. They all have data for baseline analysis. They all have data for baseline BDI and centre membership, but 110 of BDI and centre membership, but 110 of them have a missing 6-month BDI score. them have a missing 6-month BDI score. Here, we again assume that these missing Here, we again assume that these missing data are ignorable. All analyses presented data are ignorable. All analyses presented in Table 4 are based on the exclusion restricin Table 4 are based on the exclusion restriction (allocation to the treatment group has tion (allocation to the treatment group has no effect on the non-compliers). Section no effect on the non-compliers). Section (a) of Table 4 gives the results of fitting a (a) of Table 4 gives the results of fitting a CACE model in which baseline BDI and CACE model in which baseline BDI and centre membership are allowed to predict centre membership are allowed to predict both compliance and outcome (BDI at both compliance and outcome (BDI at 6 months). The model also allows for a 6 months). The model also allows for a treatment treatment6 6centre interaction (i.e. CACE centre interaction (i.e. CACE estimates are free to vary from one centre estimates are free to vary from one centre to another). There is variation between cento another). There is variation between centres but note, again, that compliance A leads tres but note, again, that compliance A leads to greater estimated treatment effects than to greater estimated treatment effects than compliance B. compliance B.
In section (b) of Table 4 we present the In section (b) of Table 4 we present the results of separate estimations for problemresults of separate estimations for problemsolving and psychoeducation. These were solving and psychoeducation. These were obtained by fitting a single model to obtained by fitting a single model to the complete data-set in which baseline the complete data-set in which baseline BDI score and centre membership were BDI score and centre membership were allowed to predict both compliance and allowed to predict both compliance and the 6-month BDI score. There were no the 6-month BDI score. There were no treatment treatment6 6centre interactions in the modcentre interactions in the model. Fitting a common treatment effect el. Fitting a common treatment effect (Table 4 , section (c)) indicates that, (Table 4 , section (c)) indicates that, although problem-solving appears to be although problem-solving appears to be slightly more effective than psychoslightly more effective than psychoeducation, the difference is nowhere near education, the difference is nowhere near statistically significant: twice the difference statistically significant: twice the difference in log in logL L, that is 2 , that is 26 6(1272. 33 (1272.337 71272.20) , is 1272.20), is distributed as distributed as w w 2 2 with one degree of freewith one degree of freedom under the null hypothesis that the dom under the null hypothesis that the two treatments are equally effective. A two treatments are equally effective. A similar comparison of the 2log similar comparison of the 2logL L values for values for the models in sections (a) and (c) also the models in sections (a) and (c) also indicates that the treatment indicates that the treatment6 6centre intercentre interactions are not statistically significant. actions are not statistically significant. However, the common treatment effects However, the common treatment effects (using either compliance A or B) in section (using either compliance A or B) in section (c) are statistically significant: by refitting (c) are statistically significant: by refitting the model after constraining the treatment the model after constraining the treatment effects to be zero, the change in 2log effects to be zero, the change in 2logL L is is 9.32 and 8.06, each with one degree of 9.32 and 8.06, each with one degree of freedom, for compliances A and B, respecfreedom, for compliances A and B, respectively. Section (d) of Table 4 provides an estively. Section (d) of Table 4 provides an estimate of the ITT effect obtained by direct timate of the ITT effect obtained by direct estimation in estimation in Mplus Mplus, assuming that missing , assuming that missing 6-month BDI scores are ignorable. 6-month BDI scores are ignorable.
Sensitivity of CACE estimates Sensitivity of CACE estimates to assumptions to assumptions
We now consider the results of our final We now consider the results of our final series of sensitivity analyses. We start by series of sensitivity analyses. We start by 3 2 7 3 2 7 Table 3  Table 3 Observed Beck Depression Inventory scores at baseline and 6 months (using compliance A)
Observed Beck Depression Inventory scores at baseline and 6 months (using compliance A) 1. Data from every patient randomised (total 1. Data from every patient randomised (total n n¼427). 427).
replacing the exclusion restriction (effect of replacing the exclusion restriction (effect of treatment allocation in the non-compliers is treatment allocation in the non-compliers is zero) by a series of alternative assumptions: zero) by a series of alternative assumptions: the effect of treatment allocation in the the effect of treatment allocation in the non-compliers varies from non-compliers varies from 7 72.5 (beneficial 2.5 (beneficial to be allocated to treatment) to +2.5 (beneto be allocated to treatment) to +2.5 (beneficial to be allocated to the control group). ficial to be allocated to the control group). This procedure was carried out for data This procedure was carried out for data using either of the two compliance definiusing either of the two compliance definitions. In each case the fitted model was tions. In each case the fitted model was equivalent to that in section (c) of Table  equivalent to that in section (c) of Table  4 . The rationale for the procedure is ex-4. The rationale for the procedure is explained in detail by Heckman plained in detail by Heckman et al et al (1998 ) (1998 ) and Jo (2002 and Jo (2002a . Because the overall effect ). Because the overall effect of allocation to treatment is a weighted of allocation to treatment is a weighted average of the effect in the compliers (the average of the effect in the compliers (the CACE) and that in the non-compliers, we CACE) and that in the non-compliers, we would expect that fixing the effect of would expect that fixing the effect of allocation in the non-compliers to a allocation in the non-compliers to a negative value would bring the CACE negative value would bring the CACE estimate closer to zero. When the effect in estimate closer to zero. When the effect in the non-compliers is the non-compliers is 7 72.5, for example, 2.5, for example, the modified CACE estimate is the modified CACE estimate is 7 73.18 3.18 (s.e. (s.e.¼3.66). On the other hand, when the 3.66). On the other hand, when the effect in the non-compliers is fixed at +2.5 effect in the non-compliers is fixed at +2.5 the CACE estimate is more marked, at the CACE estimate is more marked, at 7 76.04 (s.e.
6.04 (s.e.¼1.73). Because we set the fixed 1.73). Because we set the fixed values of the effect in the non-compliers values of the effect in the non-compliers between between 7 72.5 and +2.5, the CACE esti-2.5 and +2.5, the CACE estimates (and their standard errors) move mates (and their standard errors) move smoothly between these two extremes. smoothly between these two extremes. Because our working model (section (c) of Because our working model (section (c) of Table 4 ) has no treatment Table 4 ) has no treatment6 6centre or treatcentre or treatment ment6 6baseline BDI interactions, it is possbaseline BDI interactions, it is possible to relax the exclusion restriction and ible to relax the exclusion restriction and allow for the effect of treatment allocation allow for the effect of treatment allocation to be estimated freely in the non-compliers to be estimated freely in the non-compliers (Jo, 2002 (Jo, 2002b . For compliance A, the esti-). For compliance A, the estimated effect for the non-compliers was mated effect for the non-compliers was +1.43 (s.e. +1.43 (s.e.¼5.83); using compliance B, it 5.83); using compliance B, it was +1.41 (s.e. was +1.41 (s.e.¼13.67). The corresponding 13.67). The corresponding CACE estimates were CACE estimates were 7 75.81 (s.e. 5.81 (s.e.¼3.75) 3.75) and and 7 74.13 (s.e. 4.13 (s.e.¼5.07), respectively. Note 5.07), respectively. Note that all four of these estimates are quite imthat all four of these estimates are quite imprecise. In our final models, we constrained precise. In our final models, we constrained the effects of treatment allocation to be the the effects of treatment allocation to be the same for compliers and non-compliers. This same for compliers and non-compliers. This might seem strange but it is possible that might seem strange but it is possible that offering treatment is beneficial but its reoffering treatment is beneficial but its receipt is not. The resulting joint estimates ceipt is not. The resulting joint estimates ( (7 72.51 (s.e.
2.51 (s.e.¼1.02) and 1.02) and 7 72.46 (s.e. 2.46 (s.e.¼1.02) 1.02) using compliances A and B, respectively) using compliances A and B, respectively) are very similar to the ITT estimate (with are very similar to the ITT estimate (with similar standard errors) in section (d) of similar standard errors) in section (d) of Table 4 . We conclude that the CACE Table 4 . We conclude that the CACE estimates are reasonably robust to changes estimates are reasonably robust to changes in assumptions and the effect of the receipt in assumptions and the effect of the receipt of treatment in those who get treated is of treatment in those who get treated is likely to be somewhere between likely to be somewhere between 7 75 and 5 and 7 74 points on the BDI scale.
4 points on the BDI scale.
DISCUSSION DISCUSSION
Technical issues Technical issues
We have presented methods for the estimatWe have presented methods for the estimattion of various average treatment effects in tion of various average treatment effects in randomised controlled trials in which not randomised controlled trials in which not everyone complies with the allocated treateveryone complies with the allocated treatment. The trial that we have used to illusment. The trial that we have used to illustrate these methods (ODIN) involved trate these methods (ODIN) involved simply allocating patients to be offered simply allocating patients to be offered psychological treatment or not. The psychological treatment or not. The control group were not given access to control group were not given access to treatment and therefore the only form of treatment and therefore the only form of non-compliance possible in this trial was non-compliance possible in this trial was for those offered treatment not to accept for those offered treatment not to accept the offer or to discontinue treatment once the offer or to discontinue treatment once it had been started. In other trials it might it had been started. In other trials it might be possible for patients allocated to the be possible for patients allocated to the control group, for example, to get access control group, for example, to get access to treatment outside of the trial. Dunn to treatment outside of the trial. Dunn (2002 Dunn ( (2002b discusses an example like this. ) discusses an example like this. The simple methods of CACE estimation The simple methods of CACE estimation such as those involving the use of moments, such as those involving the use of moments, based on equations (3) and (4) of the prebased on equations (3) and (4) of the present paper, are quite straightforward to sent paper, are quite straightforward to apply. The more sophisticated maximum apply. The more sophisticated maximum likelihood procedures, however, need more likelihood procedures, however, need more technical expertise and experience. It is technical expertise and experience. It is straightforward to apply similar statistical straightforward to apply similar statistical methods to binary (depressed/not demethods to binary (depressed/not depressed) outcomes and the simpler pressed) outcomes and the simpler approaches are illustrated by Dunn approaches are illustrated by Dunn (2002 Dunn ( (2002a . ).
One point that we should stress here is One point that we should stress here is that all analyses, however simple, are that all analyses, however simple, are vitally dependent on assumptions that vitally dependent on assumptions that might be difficult to justify for a given trial might be difficult to justify for a given trial and often can be almost impossible to veriand often can be almost impossible to verify. Some of the assumptions will, however, fy. Some of the assumptions will, however, be much more credible than others. This be much more credible than others. This means that there is no one approach to means that there is no one approach to 3 2 8 3 2 8 Hollis & Campbell (1999) found that only Hollis & Campbell (1999) found that only one report included any attempt at a sensione report included any attempt at a sensitivity analysis. However, our analysis strattivity analysis. However, our analysis strategy is presented as an informal suggestion egy is presented as an informal suggestion and not a prescription. Our aim is to encouand not a prescription. Our aim is to encourage trial statisticians and others to probe rage trial statisticians and others to probe their data in more detail. We emphasise, their data in more detail. We emphasise, however, that we are not suggesting that however, that we are not suggesting that ITT methods be abandoned but that more ITT methods be abandoned but that more care should be taken in their use and they care should be taken in their use and they should be supplemented by CACE-based should be supplemented by CACE-based methods as described above. The best methods as described above. The best method of analysis must be dependent on method of analysis must be dependent on the characteristic of the trial under the characteristic of the trial under consideration. consideration.
The challenge of patient The challenge of patient preference preference
One of the major challenges for psychoOne of the major challenges for psychological treatment trials is that the patients logical treatment trials is that the patients cannot be blinded. Therapists need the cocannot be blinded. Therapists need the cooperation and often the active participation operation and often the active participation of their subjects for the success of the of their subjects for the success of the therapy. The preferences and other beliefs therapy. The preferences and other beliefs of the patients may have an important of the patients may have an important impact on compliance with an offered impact on compliance with an offered treatment and also on the efficacy of the treatment and also on the efficacy of the treatment actually received. To date, there treatment actually received. To date, there are only a few intervention studies that are only a few intervention studies that have evaluated whether patient preference have evaluated whether patient preference for a specific treatment has an effect on for a specific treatment has an effect on treatment outcome (Bedi treatment outcome (Bedi et al et al, 2000; Ward , 2000; Ward et al et al, 2000) . The interpretation of the , 2000). The interpretation of the results of a randomised controlled trial of results of a randomised controlled trial of a psychological intervention is particularly a psychological intervention is particularly challenging in the presence of these preferchallenging in the presence of these preference effects (Brewin & Bradley, 1989; ence effects (Brewin & Bradley, 1989; McPherson & Britton, 2001) . A statistical McPherson & Britton, 2001) . A statistical analysis strategy that highlights the effects analysis strategy that highlights the effects of preferences, in the present case through of preferences, in the present case through concentration on the problems of nonconcentration on the problems of noncompliance and subsequent loss to followcompliance and subsequent loss to followup, may rest on challengeable assumptions up, may rest on challengeable assumptions but the process of making these assumpbut the process of making these assumptions and offering them to challenge will tions and offering them to challenge will lead to a clearer understanding of what lead to a clearer understanding of what we need to concentrate on in interpreting we need to concentrate on in interpreting the resulting estimates. It might be partithe resulting estimates. It might be particularly helpful to consider the definition cularly helpful to consider the definition of compliance and what we think the sepaof compliance and what we think the separate effects of an offer of psychological rate effects of an offer of psychological intervention (or failure to offer in the case intervention (or failure to offer in the case of the control group) on the compliers of the control group) on the compliers and non-compliers might be. and non-compliers might be.
Does the mere offer of treatment Does the mere offer of treatment have a therapeutic effect? have a therapeutic effect?
One of the key assumptions in the analyses One of the key assumptions in the analyses presented in this paper is the exclusion presented in this paper is the exclusion restriction -the assumption that the offer restriction -the assumption that the offer of treatment in itself does not have any of treatment in itself does not have any effect on outcome. This assumption is effect on outcome. This assumption is necessary to ensure the identifiability of necessary to ensure the identifiability of the CACE estimates (i.e. can we get unique the CACE estimates (i.e. can we get unique estimates from the data?) when we do not estimates from the data?) when we do not have access to baseline covariates. When have access to baseline covariates. When we have access to covariates, which can we have access to covariates, which can be used to predict jointly the compliance be used to predict jointly the compliance and outcome, then when given an approand outcome, then when given an appropriate model (Jo, 2002 priate model (Jo, 2002b we can relax the ) we can relax the restriction assumption and actually estirestriction assumption and actually estimate the effect of offering treatment in mate the effect of offering treatment in the non-compliers. Unfortunately, in the the non-compliers. Unfortunately, in the present example the effect was only weakly present example the effect was only weakly identified (it was estimated with very large identified (it was estimated with very large standard errors). Interestingly, however, standard errors). Interestingly, however, the estimate of treatment allocation in the the estimate of treatment allocation in the non-compliers was positive (i.e. it was non-compliers was positive (i.e. it was slightly harmful to be offered treatment if slightly harmful to be offered treatment if you were then going to decline the offer). you were then going to decline the offer). Similar findings were obtained by Jo Similar findings were obtained by Jo (2002 Jo ( (2002b in his reanalysis of the JOBS II trial ) in his reanalysis of the JOBS II trial (Vinokur (Vinokur et al et al, 1995; Vinokur & Schul, , 1995; Vinokur & Schul, 1997) . The JOBS II was a randomised trial 1997). The JOBS II was a randomised trial to prevent poor mental health and to to prevent poor mental health and to promote high-quality re-employment promote high-quality re-employment among the unemployed. The overall level among the unemployed. The overall level of compliance with the offered treatment of compliance with the offered treatment (5 half-day training sessions) was similar (5 half-day training sessions) was similar to that in the ODIN trial. Jo (2002 to that in the ODIN trial. Jo (2002b b) ) argued that the offer of intervention to the argued that the offer of intervention to the non-compliers is likely to have led to non-compliers is likely to have led to demoralisation arising from their failure demoralisation arising from their failure to take up the offered treatment. The nonto take up the offered treatment. The noncompliers in the control group do not suffer compliers in the control group do not suffer this demoralisation, however, because they this demoralisation, however, because they have not been offered anything. have not been offered anything.
In our compliance A, patients who initiIn our compliance A, patients who initially accepted the offer of treatment but who ally accepted the offer of treatment but who subsequently failed to turn up for appointsubsequently failed to turn up for appointments or discontinued their treatment after ments or discontinued their treatment after having started it were classified along with having started it were classified along with the refusals as 'non-compliers'. It could be the refusals as 'non-compliers'. It could be argued, however, that those who disargued, however, that those who discontinued their treatment were partial comcontinued their treatment were partial compliers who might have received some pliers who might have received some benefit from the offered intervention. Here benefit from the offered intervention. Here it might be better to think of our comit might be better to think of our complier/non-complier dichotomy as a comparplier/non-complier dichotomy as a comparison of patients with high compliance with ison of patients with high compliance with those of low compliance (Jo, 2002 those of low compliance (Jo, 2002b b) . If this ). If this were indeed the correct interpretation, then were indeed the correct interpretation, then we might expect the offer of treatment to we might expect the offer of treatment to have a small beneficial effect in the low have a small beneficial effect in the low compliers and a larger beneficial effect in compliers and a larger beneficial effect in the high compliers. In our compliance B, the high compliers. In our compliance B, however, we put the discontinued patients however, we put the discontinued patients in with those who attended a full course in with those who attended a full course of treatment. The non-compliers in this of treatment. The non-compliers in this case might be labelled accurately as noncase might be labelled accurately as noncompliers, whereas the compliers are a compliers, whereas the compliers are a mix of high and low compliers. However, mix of high and low compliers. However, the effect of treatment allocation in the the effect of treatment allocation in the non-compliers was not seen to be beneficial non-compliers was not seen to be beneficial using either compliance A or B, but the using either compliance A or B, but the CACE estimate was more marked (further CACE estimate was more marked (further from zero) when using compliance A than from zero) when using compliance A than compliance B. One possible explanation is compliance B. One possible explanation is that the treatment had no more benefit in that the treatment had no more benefit in those who discontinued than in those who those who discontinued than in those who refused or failed to turn up for any treatrefused or failed to turn up for any treatment. In this situation the CACE estimated ment. In this situation the CACE estimated using compliance A gives us the more using compliance A gives us the more realistic treatment effect because that realistic treatment effect because that obtained using compliance B will be attenuobtained using compliance B will be attenuated towards zero by including the disated towards zero by including the discontinued patients with those who fully continued patients with those who fully complied with the offered therapy. complied with the offered therapy.
Is there evidence of resentful Is there evidence of resentful demoralisation demoralisation
In the ODIN trial the compliers in the conIn the ODIN trial the compliers in the control group (i.e. those who would have trol group (i.e. those who would have accepted the treatment if they had been accepted the treatment if they had been offered it) do worse than the nonoffered it) do worse than the noncompliers. Why? One possible intercompliers. Why? One possible interpretation is that those people who would pretation is that those people who would like help (and would have accepted treatlike help (and would have accepted treatment if offered it) but who are denied ment if offered it) but who are denied access to it because of allocation to the access to it because of allocation to the control group suffer from resentful decontrol group suffer from resentful demoralisation (Brewin & Bradley, 1989) . moralisation (Brewin & Bradley, 1989) . They do worse than they would have done They do worse than they would have done if they had never been recruited to the trial. if they had never been recruited to the trial. This resentful demoralisation, if present, This resentful demoralisation, if present, would lead to the CACE estimate being would lead to the CACE estimate being too optimistic. An alternative interpretation too optimistic. An alternative interpretation is that the non-compliers are patients who is that the non-compliers are patients who think (on the whole, correctly) that they think (on the whole, correctly) that they will get better anyway and therefore do will get better anyway and therefore do not need the offered treatment (the not need the offered treatment (the compliers, on the other hand, are sicker compliers, on the other hand, are sicker and feel more in need of help). These two and feel more in need of help). These two interpretations cannot be distinguished interpretations cannot be distinguished from the present data. The design of trials from the present data. The design of trials to enable separate estimation of treatment to enable separate estimation of treatment and preference effects would need a lot of and preference effects would need a lot of careful thought. A starting point might be careful thought. A starting point might be the two-stage design proposed by Rucker the two-stage design proposed by Rü cker (1989) -first randomise patients to have a (1989) -first randomise patients to have a choice or not, and then randomise those choice or not, and then randomise those without a choice to the competing treatwithout a choice to the competing treatments while, at the same time, allowing ments while, at the same time, allowing those allocated to the choice arm to select those allocated to the choice arm to select their own treatment. Rucker's design, howtheir own treatment. Rü cker's design, however, is probably impractical because it ever, is probably impractical because it takes little account of reality (i.e. the protakes little account of reality (i.e. the proposed analysis assumes complete compliposed analysis assumes complete compliance with the two random allocations and ance with the two random allocations and also that there will be complete follow-up also that there will be complete follow-up data). The so-called patient preference data). The so-called patient preference design of Brewin & Bradley (1989) , despite design of Brewin & Bradley (1989) , despite its popularity among some clinical its popularity among some clinical researchers, would appear to be a blind researchers, would appear to be a blind alley -it has very little validity from a alley -it has very little validity from a statistical viewpoint. A useful device might statistical viewpoint. A useful device might be to seek patient preferences prior to be to seek patient preferences prior to randomisation (Torgerson randomisation (Torgerson et al et al, 1996) . , 1996). This would not only provide important This would not only provide important information on preference effects but also information on preference effects but also would lead to better prediction of compliwould lead to better prediction of compliance and more efficient (precise) CACE ance and more efficient (precise) CACE estimates. Interestingly, investigators in estimates. Interestingly, investigators in one of the Norwegian centres of the ODIN one of the Norwegian centres of the ODIN trial informed us after the above analysis trial informed us after the above analysis that they had asked patients prior to that they had asked patients prior to randomisation about their interest in randomisation about their interest in receiving the treatment (as suggested in receiving the treatment (as suggested in Torgerson Torgerson et al et al, 1996) . Those patients , 1996) . Those patients who were allocated to the control condition who were allocated to the control condition but had expressed an interest in the treatbut had expressed an interest in the treatment prior to randomisation appeared to ment prior to randomisation appeared to do worse than those who had not (Dalgard do worse than those who had not (Dalgard & Børve, 2000) . & Børve, 2000).
Concluding remarks Concluding remarks
In the interpretation and evaluation of the In the interpretation and evaluation of the results of a simple randomised controlled results of a simple randomised controlled trial such as ODIN one can ask two related trial such as ODIN one can ask two related and complementary questions: 'What is the and complementary questions: 'What is the effect of offering treatment?' and 'What is effect of offering treatment?' and 'What is the effect of the receipt of treatment?' The the effect of the receipt of treatment?' The former is answered using an ITT estimate former is answered using an ITT estimate of the treatment effect (i.e. the impact of of the treatment effect (i.e. the impact of randomisation) and the latter through randomisation) and the latter through CACE estimation (i.e. adjusting for non-CACE estimation (i.e. adjusting for noncompliance). The answers to both questions compliance). The answers to both questions are likely to be interesting and important are likely to be interesting and important and it is reasonably straightforward to and it is reasonably straightforward to obtain answers to both. We stress that in obtain answers to both. We stress that in promoting the use of CACE estimation we promoting the use of CACE estimation we are not advocating that trialists should are not advocating that trialists should abandon ITT. This should always be the abandon ITT. This should always be the primary analysis. What we are advocating primary analysis. What we are advocating is that trialists move beyond ITT in order is that trialists move beyond ITT in order to learn more from their data and search to learn more from their data and search for explanations for their primary results. for explanations for their primary results. Estimation of the complier average causal effect (CACE) enables one to evaluate the effect of receipt of treatment in a randomised controlled trial in which a the effect of receipt of treatment in a randomised controlled trial in which a proportion of patients do not comply with their allocated treatment. proportion of patients do not comply with their allocated treatment.
& & Estimation of CACE should not be seen as an alternative to the pragmatic Estimation of CACE should not be seen as an alternative to the pragmatic intention-to-treat (ITT) analysis but as a means of going beyond ITTestimates to intention-to-treat (ITT) analysis but as a means of going beyond ITTestimates to seek an explanation for the pragmatic effects. seek an explanation for the pragmatic effects.
& & The CACE estimates present trial results in a way that is closer to the real world of
The CACE estimates present trial results in a way that is closer to the real world of the practicing clinician than ITTestimates of treatment effects, and therefore may be the practicing clinician than ITTestimates of treatment effects, and therefore may be more clinically relevant. more clinically relevant.
LIMITATIONS LIMITATIONS
& & The CACE analysis presented here assumes that the specified intervention is not
The CACE analysis presented here assumes that the specified intervention is not available to patients outside of the trial condition. However, the methods can be available to patients outside of the trial condition. However, the methods can be extended easily to cope with more complex situations. extended easily to cope with more complex situations.
& & Estimation of CACE assumes that compliance is a dichotomous (yes/no) condition, Estimation of CACE assumes that compliance is a dichotomous (yes/no) condition, whereas patients may have differing degrees of compliance. Again, the methodology whereas patients may have differing degrees of compliance. Again, the methodology can be extended to cope with quantitative compliance^response relationships. can be extended to cope with quantitative compliance^response relationships.
& & Estimation of CACE is dependent upon potentially challengeable assumptions that
Estimation of CACE is dependent upon potentially challengeable assumptions that frequently cannot be tested using the data at hand.These challenges should, however, frequently cannot be tested using the data at hand.These challenges should, however, stimulate investigators to come up with more informative designs. stimulate investigators to come up with more informative designs.
